Stock Performance and Market Context
On 26 May 2026, Park Medi World Ltd's stock price surged to Rs.284.75, setting a fresh 52-week and all-time high. This milestone was achieved amid a day’s gain of 1.26%, outperforming the broader Sensex, which marginally declined by 0.02%. The stock opened with a gap up of 2.05% and touched an intraday high of Rs.284.75, representing a 2.17% increase from the previous close.
The stock has demonstrated a robust upward trajectory over recent sessions, recording a consecutive gain over the last three days with a cumulative return of 9.58%. This momentum has outpaced the hospital sector, with Park Medi World outperforming its peers by 1.23% on the day.
Comparative Performance Over Time
Examining the stock’s performance over various time frames highlights its strong relative strength. Over the past week, Park Medi World Ltd has appreciated by 14.11%, significantly higher than the Sensex’s 1.69% gain. The one-month return stands at 21.59%, contrasting with the Sensex’s slight decline of 0.25%. Over three months, the stock has surged by 47.98%, while the Sensex has fallen by 7.02% in the same period.
Year-to-date, the stock has delivered an impressive 92.50% return, vastly outperforming the Sensex’s negative 10.26% performance. This strong showing underscores the stock’s resilience and appeal within its sector. However, over longer horizons such as one year, three years, five years, and ten years, the stock’s performance is recorded as flat (0.00%), reflecting either a recent listing or data unavailability for those periods.
Technical Indicators and Trend Analysis
Technically, Park Medi World Ltd is in a mildly bullish phase, having shifted from a sideways trend on 19 May 2026 at a price level of Rs.247.30. The stock is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained upward momentum.
Key technical indicators provide a mixed but generally positive outlook. Bollinger Bands and Dow Theory signals are bullish, while the Relative Strength Index (RSI) currently shows no signal, and On-Balance Volume (OBV) indicates no clear trend. Immediate support is established at the 52-week low of Rs.138.15, while the immediate resistance was previously near the 20-day moving average at Rs.247.09, now decisively surpassed. The all-time high of Rs.284.75 represents a far resistance level that the stock has just breached.
Valuation Metrics
At the current price of approximately Rs.282.20, Park Medi World Ltd trades at a price-to-earnings (P/E) ratio of 50 times trailing twelve months (TTM) earnings, indicating a premium valuation relative to earnings. The price-to-book value (P/BV) stands at 5.94 times, while enterprise value multiples include EV/EBITDA at 26.88 times and EV/EBIT at 31.27 times. The EV/Sales multiple is 7.11 times, and EV/Capital Employed is 6.11 times. These multiples suggest that the market is valuing the company at a premium, consistent with its recent strong price performance.
Dividend metrics are not applicable, with no dividend yield, payout, or ex-dividend date reported.
Quality and Financial Health
Park Medi World Ltd’s quality assessment reflects a company with a strong balance sheet and prudent capital structure. The management risk is rated as good, and the capital structure is also considered good, with low leverage indicated by an average debt to EBITDA ratio of 1.33 and net debt to equity at zero. The company has no promoter share pledging, which supports confidence in governance.
Financially, the company exhibits an average return on capital employed (ROCE) of 21.20%, a strong indicator of efficient capital utilisation. However, average return on equity (ROE) is reported as zero, which may reflect recent earnings patterns or accounting factors. Sales and EBIT growth over five years are flat at 0.0%, indicating stable but non-expansive growth over the medium term.
Recent Financial Trends
In the short term, the company’s financial trend is flat as of March 2026. Quarterly profit after tax (PAT) has grown by 28.7% to ₹8.61 crores compared to the previous four-quarter average, signalling improved profitability. Conversely, profit before tax excluding other income has declined by 80.5% to ₹1.34 crores, and net sales have fallen by 11.9% to ₹27.43 crores in the same period. Non-operating income constitutes a significant 86.06% of profit before tax, indicating reliance on income sources outside core operations.
Trading Volumes and Market Capitalisation
Trading activity has intensified, with delivery volumes on 25 May 2026 reaching 11.35 lakh shares, representing 39.69% of total volume and a 293.95% increase compared to the five-day average. The one-month delivery volume has increased by 2.38%, reflecting growing investor participation. Park Medi World Ltd is classified as a small-cap stock, with a Mojo Score of 60.0 and a Mojo Grade of Hold, as per MarketsMOJO’s latest assessment. This rating reflects a balanced view of the stock’s current valuation and quality metrics.
Summary
Park Medi World Ltd’s achievement of an all-time high price of Rs.284.75 on 26 May 2026 marks a significant milestone in its market journey. The stock’s recent strong performance, supported by positive technical signals and solid quality indicators, has propelled it well above key moving averages and resistance levels. While valuation multiples suggest a premium pricing, the company’s strong ROCE and prudent capital structure underpin its financial stability. The mixed short-term financial trends highlight areas of both strength and caution, with profitability growth tempered by declines in core sales and operating profit before other income.
This milestone reflects the culmination of sustained gains and market confidence in Park Medi World Ltd’s position within the hospital sector, underscoring its noteworthy performance in a competitive industry landscape.
